RE-ASSESSMENT OF RISK OF RE-BLEEDING OF FORREST IB (OOZING) PEPTIC ULCER BLEEDING (PUB)

(1) David Geffen School of Medicine at UCLA, and CURE Digestive Diseases Research Center, Los Angeles, United States

(2) Department of Surgery, Glasgow Royal Infirmary, Glasgow, United Kingdom

(3) AstraZeneca R&D, Molndal, Sweden

(4) Division of Gastroenterology, McGill University, Montreal, Canada

(5) Departments of Gastroenterology and Hepatology, and Internal Medicine, Erasmus MC University Medical Center, Rotterdam, Netherlands

(6) Medizinische Klinik und Poliklinik II, University of Leipzig, Leipzig, Germany

(7) Institute of Digestive Diseases, University of Hong Kong, Hong Kong, China



This item was part of the Gastrointestinal bleeding session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A92